Chaewon Baek
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Chaewon Baek has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Abdul Hadee
Department of Smart Air Mobility, Korea Aerospace University, Goyang-si, Gyeonggi-do, Republic of Korea
1 shared publication - Ahmad Bilal
Department of Electrical and Electronic Engineering, Korea Aerospace University, Goyang, Korea
1 shared publication - Choon Sik Cho
Department of Electrical and Electronic Engineering, Korea Aerospace University, Goyang, Korea
1 shared publication - Hae-Been Han
University of Seoul
1 shared publication - Hae-Chan Hong
School of Electrical and Computer Engineering, University of Seoul, Dongdaemun-gu, Seoul, Republic of Korea
1 shared publication Jeeln Choi
Department of Rehabilitation Medicine, Rehabilitation and Regeneration Research Center, CHA Bundang Medical Center, CHA University, Seongnam, Republic of Korea
1 shared publication
Latest Publications
- 16 May 2025
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Antennas and Propagation
- Vol. 73 (9) , 6788-6799
In Vitro Treatment of Alzheimer’s Disease by Disintegrating Amyloid- β Using Electromagnetic Waves
The amyloid- beta (Aβ) protein is a peptide that plays a central role in the development and progression of Alzheimer's disease, originating from the cleavage of the amyloid precursor protein (APP). The peptide's structural variability is linked to different stages and manifestations of Alzheimer's pathology, making it a critical focus for understanding the disease. Current therapeutic strategies primarily involve pharmacological interventions, but they have met with limited success in altering the course of the disease. Our research introduces an innovative approach to address this challenge by employing electromagnetic waves, specifically at a frequency of 900 MHz We performed comprehensive electromagnetic simulations to explore the effects of this frequency on Aβ structures, aiming to offer an alternative non-invasive treatment avenue. Following these electromagnetic simulations, molecular dynamics (MD) simulations were carried out using the Large Scale Atomic/Molecular Massively Parallel Simulation (LAMMPS) software to further investigate the peptide’s response at the atomic and molecular level. These simulations provided insights into the structural dynamics of Aβ under electromagnetic influence, enabling a deeper understanding of the peptide’s behavior. To substantiate the findings from our simulations and the theoretical framework, we conducted a Thioflavin T (ThT) assay and western blot analysis on in vitro Aβ fibril samples which are treated with electromagnetic (EM) wave exposure using a TEM cell device. After 3 hours of EM wave exposure, a noticeable decrease in Aβ fibrils was observed. This experimental validation was essential in confirming the simulation results and reinforcing the theoretical basis of our approach. Together, simulations and experimental evidence provide a strong foundation for exploring electromagnetic-based treatments as a potential therapeutic intervention for Alzheimer’s disease.
- 16 May 2025
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Antennas and Propagation
- Vol. 73 (9) , 6788-6799
In Vitro Treatment of Alzheimer’s Disease by Disintegrating Amyloid- β Using Electromagnetic Waves
The amyloid- beta (Aβ) protein is a peptide that plays a central role in the development and progression of Alzheimer's disease, originating from the cleavage of the amyloid precursor protein (APP). The peptide's structural variability is linked to different stages and manifestations of Alzheimer's pathology, making it a critical focus for understanding the disease. Current therapeutic strategies primarily involve pharmacological interventions, but they have met with limited success in altering the course of the disease. Our research introduces an innovative approach to address this challenge by employing electromagnetic waves, specifically at a frequency of 900 MHz We performed comprehensive electromagnetic simulations to explore the effects of this frequency on Aβ structures, aiming to offer an alternative non-invasive treatment avenue. Following these electromagnetic simulations, molecular dynamics (MD) simulations were carried out using the Large Scale Atomic/Molecular Massively Parallel Simulation (LAMMPS) software to further investigate the peptide’s response at the atomic and molecular level. These simulations provided insights into the structural dynamics of Aβ under electromagnetic influence, enabling a deeper understanding of the peptide’s behavior. To substantiate the findings from our simulations and the theoretical framework, we conducted a Thioflavin T (ThT) assay and western blot analysis on in vitro Aβ fibril samples which are treated with electromagnetic (EM) wave exposure using a TEM cell device. After 3 hours of EM wave exposure, a noticeable decrease in Aβ fibrils was observed. This experimental validation was essential in confirming the simulation results and reinforcing the theoretical basis of our approach. Together, simulations and experimental evidence provide a strong foundation for exploring electromagnetic-based treatments as a potential therapeutic intervention for Alzheimer’s disease.